Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases

Mehak Passi,1,* Sadia Shahid,2,* Sankarakuttalam Chockalingam,2 Isaac Kirubakaran Sundar,3 Gopinath Packirisamy1,2 1Nanobiotechnology Laboratory, Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India; 2Department of Biotechnology, Indian Institute of T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Passi M, Shahid S, Chockalingam S, Sundar IK, Packirisamy G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	chronic obstructive pulmonary disease (copd) nanotechnology anti-oxidant therapy stem cell therapy gene therapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/def933b18fa84a84b3ac0da590ba078d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:def933b18fa84a84b3ac0da590ba078d
record_format	dspace
spelling	oai:doaj.org-article:def933b18fa84a84b3ac0da590ba078d2021-12-02T11:36:48ZConventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases1178-2013https://doaj.org/article/def933b18fa84a84b3ac0da590ba078d2020-05-01T00:00:00Zhttps://www.dovepress.com/conventional-and-nanotechnology-based-approaches-to-combat-chronic-obs-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Mehak Passi,1,* Sadia Shahid,2,* Sankarakuttalam Chockalingam,2 Isaac Kirubakaran Sundar,3 Gopinath Packirisamy1,2 1Nanobiotechnology Laboratory, Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India; 2Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India; 3Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14623, USA*These authors contributed equally to this workCorrespondence: Isaac Kirubakaran Sundar; Gopinath Packirisamy Tel +1-585-273-3034; +91-1332-285650Email isaac_sundar@urmc.rochester.edu; genegopi@gmail.comAbstract: Chronic obstructive pulmonary disease (COPD) is the most prevalent obstructive lung disease worldwide characterized by decline in lung function. It is associated with airway obstruction, oxidative stress, chronic inflammation, mucus hypersecretion, and enhanced autophagy and cellular senescence. Cigarette smoke being the major risk factor, other secondary risk factors such as the exposure to air pollutants, occupational exposure to gases and fumes in developing countries, also contribute to the pathogenesis of COPD. Conventional therapeutic strategies of COPD are based on anti-oxidant and anti-inflammatory drugs. However, traditional anti-oxidant pharmacological therapies are commonly used to alleviate the impact of COPD as they have many associated repercussions such as low diffusion rate and inappropriate drug pharmacokinetics. Recent advances in nanotechnology and stem cell research have shed new light on the current treatment of chronic airway disease. This review is focused on some of the anti-oxidant therapies currently used in the treatment and management of COPD with more emphasis on the recent advances in nanotechnology-based therapeutics including stem cell and gene therapy approaches for the treatment of chronic airway disease such as COPD and asthma.Keywords: chronic obstructive pulmonary disease, COPD, nanotechnology, anti-oxidant therapy, stem cell therapy, gene therapyPassi MShahid SChockalingam SSundar IKPackirisamy GDove Medical Pressarticlechronic obstructive pulmonary disease (copd)nanotechnologyanti-oxidant therapystem cell therapygene therapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 3803-3826 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	chronic obstructive pulmonary disease (copd) nanotechnology anti-oxidant therapy stem cell therapy gene therapy Medicine (General) R5-920
spellingShingle	chronic obstructive pulmonary disease (copd) nanotechnology anti-oxidant therapy stem cell therapy gene therapy Medicine (General) R5-920 Passi M Shahid S Chockalingam S Sundar IK Packirisamy G Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases
description	Mehak Passi,1,* Sadia Shahid,2,* Sankarakuttalam Chockalingam,2 Isaac Kirubakaran Sundar,3 Gopinath Packirisamy1,2 1Nanobiotechnology Laboratory, Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India; 2Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India; 3Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14623, USA*These authors contributed equally to this workCorrespondence: Isaac Kirubakaran Sundar; Gopinath Packirisamy Tel +1-585-273-3034; +91-1332-285650Email isaac_sundar@urmc.rochester.edu; genegopi@gmail.comAbstract: Chronic obstructive pulmonary disease (COPD) is the most prevalent obstructive lung disease worldwide characterized by decline in lung function. It is associated with airway obstruction, oxidative stress, chronic inflammation, mucus hypersecretion, and enhanced autophagy and cellular senescence. Cigarette smoke being the major risk factor, other secondary risk factors such as the exposure to air pollutants, occupational exposure to gases and fumes in developing countries, also contribute to the pathogenesis of COPD. Conventional therapeutic strategies of COPD are based on anti-oxidant and anti-inflammatory drugs. However, traditional anti-oxidant pharmacological therapies are commonly used to alleviate the impact of COPD as they have many associated repercussions such as low diffusion rate and inappropriate drug pharmacokinetics. Recent advances in nanotechnology and stem cell research have shed new light on the current treatment of chronic airway disease. This review is focused on some of the anti-oxidant therapies currently used in the treatment and management of COPD with more emphasis on the recent advances in nanotechnology-based therapeutics including stem cell and gene therapy approaches for the treatment of chronic airway disease such as COPD and asthma.Keywords: chronic obstructive pulmonary disease, COPD, nanotechnology, anti-oxidant therapy, stem cell therapy, gene therapy
format	article
author	Passi M Shahid S Chockalingam S Sundar IK Packirisamy G
author_facet	Passi M Shahid S Chockalingam S Sundar IK Packirisamy G
author_sort	Passi M
title	Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases
title_short	Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases
title_full	Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases
title_fullStr	Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases
title_full_unstemmed	Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases
title_sort	conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/def933b18fa84a84b3ac0da590ba078d
work_keys_str_mv	AT passim conventionalandnanotechnologybasedapproachestocombatchronicobstructivepulmonarydiseaseimplicationsforchronicairwaydiseases AT shahids conventionalandnanotechnologybasedapproachestocombatchronicobstructivepulmonarydiseaseimplicationsforchronicairwaydiseases AT chockalingams conventionalandnanotechnologybasedapproachestocombatchronicobstructivepulmonarydiseaseimplicationsforchronicairwaydiseases AT sundarik conventionalandnanotechnologybasedapproachestocombatchronicobstructivepulmonarydiseaseimplicationsforchronicairwaydiseases AT packirisamyg conventionalandnanotechnologybasedapproachestocombatchronicobstructivepulmonarydiseaseimplicationsforchronicairwaydiseases
_version_	1718395793334861824

Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases

Ejemplares similares